TPOP146
TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with Kd values of 134 nM and 5.02 μM for CBP and BRD4.
Product Specifications
CAS Number
2018300-62-2
UNSPSC
12352005
Target
Epigenetic Reader Domain; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/TPOP146.html
Purity
98.94
Solubility
DMSO : 21.43 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COC1=CC(OC)=CC(C2=CC(C(N[C@H]3CCCN(C)C3)=O)=C(OCCN(C(CC)=O)C4)C4=C2)=C1
Molecular Formula
C27H35N3O5
Molecular Weight
481.58
References & Citations
[1]Popp TA, et al. Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors. J Med Chem. 2016 Oct 13;59 (19) :8889-8912.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P4258-98-ML750 100 µL
Platelet-derived Growth Factor D, ID (SCDGFB, PDGF-D, Iris-expressed Growth Factor, Spinal Cord-derived Growth Factor B, SCDGF-B, Pdgfd, Iegf) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
RA0631-01 100 µg
Suptavumab (Biosimilar Reference Antibody) (Respiratory Syncytial Virus Glycoprotein F)
Sign In for Pricing
View Details RA0631-02 1 mg
Suptavumab (Biosimilar Reference Antibody) (Respiratory Syncytial Virus Glycoprotein F)
Sign In for Pricing
View Details RA0631-03 5 mg
Suptavumab (Biosimilar Reference Antibody) (Respiratory Syncytial Virus Glycoprotein F)
Sign In for Pricing
View Details RA0631-04 10 mg
Suptavumab (Biosimilar Reference Antibody) (Respiratory Syncytial Virus Glycoprotein F)
Sign In for Pricing
View Details